β 3 adrenergic agonists

Details β 3 adrenergic agonists β 3 adrenergic agonists

2007-08-07

2007-08-07

Morris, Patricia L. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S113000

Reexamination Certificate

active

11276192

ABSTRACT:
The present invention relates to pyrrolopyridine-3-yl group containing β3adrenergic receptor agonists or pharmaceutical salts thereof.

REFERENCES:
patent: 4234595 (1980-11-01), Kreighbaum et al.
patent: 4276304 (1981-06-01), Ikezaki et al.
patent: 4314943 (1982-02-01), Kreighbaum et al.
patent: 4826847 (1989-05-01), Michel et al.
patent: 5808080 (1998-09-01), Bell et al.
patent: 6011048 (2000-01-01), Mathvink et al.
patent: 6911463 (2005-06-01), Sall et al.
patent: 7087635 (2006-08-01), Sall et al.
patent: 2005/0020617 (2005-01-01), Bastian et al.
patent: 2005/0080110 (2005-04-01), Sall et al.
patent: 2006/0142328 (2006-06-01), Bastian et al.
patent: 2006/0142329 (2006-06-01), Bastian et al.
patent: 0 166 331 (1986-01-01), None
patent: 0 221 414 (1987-05-01), None
patent: 0 236 624 (1987-09-01), None
patent: 0 611 003 (1994-08-01), None
patent: 0 678 511 (1995-10-01), None
patent: 0 764 640 (1997-03-01), None
patent: 2001633 (1979-02-01), None
patent: 1 549 945 (1979-08-01), None
patent: WO 95/29159 (1995-11-01), None
patent: WO 97/10825 (1997-03-01), None
patent: WO 97/46556 (1997-12-01), None
patent: WO 98/04526 (1998-02-01), None
patent: WO 98/09625 (1998-03-01), None
patent: WO 98/32753 (1998-07-01), None
patent: WO 00/40560 (2000-07-01), None
patent: WO 00/44721 (2000-08-01), None
patent: WO 01/07026 (2001-02-01), None
patent: WO 01/35947 (2001-05-01), None
patent: WO 01/36412 (2001-05-01), None
patent: WO 01/53298 (2001-07-01), None
patent: WO 02/06276 (2002-01-01), None
patent: WO 02/38543 (2002-05-01), None
patent: WO 03/016276 (2003-02-01), None
patent: WO 03/016307 (2003-02-01), None
Shuker, et al., “The application of high-throughput synthesis and purification to the preparation of ethanolamines,”Tetrahedron Letters, vol. 38, No. 35, pp. 6149-6152.
Weber, et al., “Potent, selective benzenesulfonamide agonists of human b3 adrenergic receptor,”Bioorganic&Medicinal Chemistry letters, vol. 8, No. 9, pp. 1101-1106 (1998).
Weber, et al., “3-Pyridyloxypropanolamine agonists of the b3 adrenergic receptor with improved pharmacokinetic properties,”Bioorganic&Medicinal Chemistry Letters, vol. 8, No. 16, pp. 2111-2116 (1998).

Affiliated with

Also associated with

Rating

β 3 adrenergic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with β 3 adrenergic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β 3 adrenergic agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3878596